State of Health

Amivantamab: A New Hope for Lung Cancer Patients


Listen Later

We explore the groundbreaking trial of Amivantamab combined with chemotherapy in treating non-small-cell lung cancer - specifically those presenting the EGFR exon 20 insertions. We delve into the trial's promising results, the significant increase in progression-free survival, and the potential of this new approach to revolutionize lung cancer treatment. Original article here.


ABOUT THE STATE OF HEALTH

The State of Health helps you understand the most important news and research in healthcare and medicine. For more visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠stateofhealth.care⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠


FOLLOW US

  • Youtube: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠youtube.com/@medzcool⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠
  • Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠instagram.com/medzcool⁠⁠⁠⁠⁠⁠⁠⁠⁠
  • Threads: ⁠⁠⁠⁠⁠⁠⁠⁠threads.net/@medzcool
  • ...more
    View all episodesView all episodes
    Download on the App Store

    State of HealthBy Medzcool

    • 5
    • 5
    • 5
    • 5
    • 5

    5

    3 ratings